Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA
Jeffrey L. Platt, Mayara Garcia de Mattos Barbosa, Daniel Huynh, Adam R. Lefferts, Juhi Katta, Cyra Kharas, Peter Freddolino, Christine M. Bassis, Christiane Wobus, Raif Geha, Richard Bram, Gabriel Nunez, Nobuhiko Kamada, Marilia Cascalho
Jeffrey L. Platt, Mayara Garcia de Mattos Barbosa, Daniel Huynh, Adam R. Lefferts, Juhi Katta, Cyra Kharas, Peter Freddolino, Christine M. Bassis, Christiane Wobus, Raif Geha, Richard Bram, Gabriel Nunez, Nobuhiko Kamada, Marilia Cascalho
View: Text | PDF
Research Article Immunology Microbiology

TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA

  • Text
  • PDF
Abstract

TNFRSF13B encodes the transmembrane activator and CAML interactor (TACI) receptor, which drives plasma cell differentiation. Although TNFRSF13B supports host defense, dominant-negative TNFRSF13B alleles are common in humans and other species and only rarely associate with disease. We reasoned that the high frequency of disruptive TNFRSF13B alleles reflects balancing selection, the loss of function conferring advantage in some settings. Testing that concept, we investigated how a common human dominant-negative variant, TNFRSF13B A181E, imparts resistance to enteric pathogens. Mice engineered to express mono- or biallelic A144E variants of tnrsf13B, corresponding to A181E, exhibited a striking resistance to pathogenicity and transmission of Citrobacter rodentium, a murine pathogen that models enterohemorrhagic Escherichia coli, and resistance was principally owed to natural IgA deficiency in the intestine. In WT mice with gut IgA and in mutant mice reconstituted with enteric IgA obtained from WT mice, IgA induces LEE expression of encoded virulence genes, which confer pathogenicity and transmission. Taken together, our results show that C. rodentium and most likely other enteric organisms appropriated binding of otherwise protective antibodies to signal induction of the virulence program. Additionally, the high prevalence of TNFRSF13B dominant-negative variants reflects balancing selection.

Authors

Jeffrey L. Platt, Mayara Garcia de Mattos Barbosa, Daniel Huynh, Adam R. Lefferts, Juhi Katta, Cyra Kharas, Peter Freddolino, Christine M. Bassis, Christiane Wobus, Raif Geha, Richard Bram, Gabriel Nunez, Nobuhiko Kamada, Marilia Cascalho

×

Figure 2

Tnfrsf13b mutations block C. rodentium virulence gene induction.

Options: View larger image (or click on image) Download as PowerPoint

Tnfrsf13b mutations block C. rodentium virulence gene induction.
(A and...
(A and B) Ler expression measured by bioluminescence of ler/lux-C. rodentium attached to the intestinal wall of mice infected for 7 days. Shown is ler expression in relative light units, RLU, in each strain (y axis). RLU reflects the photons/s measured in each image divided by the background luminescence. Comparisons done with 1-way ANOVA yielded P < 0.0001; multiple comparisons to C57BL/6 mice (control), yielded for A144E/WT, P < 0.0001; A144E/A144E, P < 0.0001; and for PIgR-KO, P < 0.0001. (C) C. rodentium in feces obtained 7 days after infection for each of the infected mouse strains. Values were analyzed by 1-way ANOVA (P < 0.000), followed by the multiple comparisons test comparing Tnfrsf13b mutant mice to WT showing P < 0.01 for A144E/WT, P < 0.05 for A144E/A144E and P < 0.0001 for PIgR-KO mice. (D) C. rodentium in feces of C57BL/6 or Tnfrsf13b mutant mice 14 days following infection with 108 C. rodentium grown overnight in DMEM medium and expressing ler. Statistical analysis was by 1-way ANOVA and the Kruskal-Wallis test followed by a multiple comparisons test. High virulence C. rodentium infects WT and Tnfrsf13b mutant mice equally (P > 0.05). (E) IgA concentration measured in feces 7 days after infection by ELISA. Comparisons done with 1-way ANOVA and the Kruskal-Wallis test yielded P < 0.0001, followed by multiple comparisons test to C57BL/6 mice yielded for A144E/WT, P < 0.0001; A144E/A144E, P = 0.0049; and for PIgR-KO, P < 0.0001. (F) Correlation analysis between luminescence reflecting ler expression by bacteria attached to the gut walls and IgA concentration in feces supernatants obtained 7 days after infection. Spearman’s test r = 0.70894, P < 0.0001 indicating that IgA concentration in feces is correlated with ler expression. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts